Literature DB >> 30046080

The amyloid hypothesis on trial.

Simon Makin.   

Abstract

Entities:  

Keywords:  Alzheimer's disease; Brain; Cell biology; Neurodegeneration

Mesh：

Substances：

Year:  2018        PMID： 30046080     DOI： 10.1038/d41586-018-05719-4

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  13 in total

1.  Herpes simplex virus type 1 in brain and risk of Alzheimer's disease.

Authors:  R F Itzhaki; W R Lin; D Shang; G K Wilcock; B Faragher; G A Jamieson
Journal:  Lancet       Date:  1997-01-25       Impact factor: 79.321

Review 2.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide.

Authors:  Christian Haass; Dennis J Selkoe
Journal:  Nat Rev Mol Cell Biol       Date:  2007-02       Impact factor: 94.444

Review 3.  Microbes and Alzheimer's Disease.

Authors:  Ruth F Itzhaki; Richard Lathe; Brian J Balin; Melvyn J Ball; Elaine L Bearer; Heiko Braak; Maria J Bullido; Chris Carter; Mario Clerici; S Louise Cosby; Kelly Del Tredici; Hugh Field; Tamas Fulop; Claudio Grassi; W Sue T Griffin; Jürgen Haas; Alan P Hudson; Angela R Kamer; Douglas B Kell; Federico Licastro; Luc Letenneur; Hugo Lövheim; Roberta Mancuso; Judith Miklossy; Carola Otth; Anna Teresa Palamara; George Perry; Christopher Preston; Etheresia Pretorius; Timo Strandberg; Naji Tabet; Simon D Taylor-Robinson; Judith A Whittum-Hudson
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

4.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease.

Authors:  A Goate; M C Chartier-Harlin; M Mullan; J Brown; F Crawford; L Fidani; L Giuffra; A Haynes; N Irving; L James
Journal:  Nature       Date:  1991-02-21       Impact factor: 49.962

5.  Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease.

Authors:  D Scheuner; C Eckman; M Jensen; X Song; M Citron; N Suzuki; T D Bird; J Hardy; M Hutton; W Kukull; E Larson; E Levy-Lahad; M Viitanen; E Peskind; P Poorkaj; G Schellenberg; R Tanzi; W Wasco; L Lannfelt; D Selkoe; S Younkin
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

6.  Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation.

Authors:  Matthew A Wozniak; Ruth F Itzhaki; Suzanne J Shipley; Curtis B Dobson
Journal:  Neurosci Lett       Date:  2007-10-13       Impact factor: 3.046

7.  Amyloid-β oligomerization in Alzheimer dementia versus high-pathology controls.

Authors:  Thomas J Esparza; Hanzhi Zhao; John R Cirrito; Nigel J Cairns; Randall J Bateman; David M Holtzman; David L Brody
Journal:  Ann Neurol       Date:  2012-12-07       Impact factor: 10.422

8.  Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques.

Authors:  M A Wozniak; A P Mee; R F Itzhaki
Journal:  J Pathol       Date:  2009-01       Impact factor: 7.996

9.  Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer's disease.

Authors:  Deepak Kumar Vijaya Kumar; Se Hoon Choi; Kevin J Washicosky; William A Eimer; Stephanie Tucker; Jessica Ghofrani; Aaron Lefkowitz; Gawain McColl; Lee E Goldstein; Rudolph E Tanzi; Robert D Moir
Journal:  Sci Transl Med       Date:  2016-05-25       Impact factor: 17.956

10.  Herpes simplex infection and the risk of Alzheimer's disease: A nested case-control study.

Authors:  Hugo Lövheim; Jonathan Gilthorpe; Anders Johansson; Sture Eriksson; Göran Hallmans; Fredrik Elgh
Journal:  Alzheimers Dement       Date:  2014-10-07       Impact factor: 21.566
View more
  91 in total

Review 1.  Alzheimer's Disease: The Link Between Amyloid-β and Neurovascular Dysfunction.

Authors:  Ernesto Solis; Kevin N Hascup; Erin R Hascup
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

2.  Reciprocal modulation between amyloid precursor protein and synaptic membrane cholesterol revealed by live cell imaging.

Authors:  Claire E DelBove; Claire E Strothman; Roman M Lazarenko; Hui Huang; Charles R Sanders; Qi Zhang
Journal:  Neurobiol Dis       Date:  2019-03-15       Impact factor: 5.996

3.  Alzheimer-Related Cerebrovascular Disease in Down Syndrome.

Authors:  Patrick J Lao; José Gutierrez; David Keator; Batool Rizvi; Arit Banerjee; Kay C Igwe; Krystal K Laing; Mithra Sathishkumar; Fahmida Moni; Howard Andrews; Sharon Krinsky-McHale; Elizabeth Head; Joseph H Lee; Florence Lai; Michael A Yassa; H Diana Rosas; Wayne Silverman; Ira T Lott; Nicole Schupf; Adam M Brickman
Journal:  Ann Neurol       Date:  2020-10-09       Impact factor: 10.422

4.  Suboptimal validity of amyloid imaging-based diagnosis and management of Alzheimer's disease: why it is time to abandon the approach.

Authors:  Abass Alavi; Jorge R Barrio; Thomas J Werner; Mohsen Khosravi; Andrew Newberg; Poul Flemming Høilund-Carlsen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-02       Impact factor: 9.236

Review 5.  Microbiota in cerebrovascular disease: A key player and future therapeutic target.

Authors:  Shuichi Tonomura; Masafumi Ihara; Robert P Friedland
Journal:  J Cereb Blood Flow Metab       Date:  2020-04-20       Impact factor: 6.200

6.  Aβ Plaques.

Authors:  Lary C Walker
Journal:  Free Neuropathol       Date:  2020-10-30

7.  A Multifunctional Chemical Agent as an Attenuator of Amyloid Burden and Neuroinflammation in Alzheimer's Disease.

Authors:  Hong-Jun Cho; Anuj K Sharma; Ying Zhang; Michael L Gross; Liviu M Mirica
Journal:  ACS Chem Neurosci       Date:  2020-05-04       Impact factor: 4.418

Review 8.  High-resolution probing of early events in amyloid-β aggregation related to Alzheimer's disease.

Authors:  Bikash R Sahoo; Sarah J Cox; Ayyalusamy Ramamoorthy
Journal:  Chem Commun (Camb)       Date:  2020-04-17       Impact factor: 6.222

9.  Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer's Disease.

Authors:  Christian Griñán-Ferré; Sandra Codony; Eugènia Pujol; Jun Yang; Rosana Leiva; Carmen Escolano; Dolors Puigoriol-Illamola; Júlia Companys-Alemany; Rubén Corpas; Coral Sanfeliu; Belen Pérez; M Isabel Loza; José Brea; Christophe Morisseau; Bruce D Hammock; Santiago Vázquez; Mercè Pallàs; Carles Galdeano
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

10.  Cardiovascular contributions to dementia: beyond individual risk factors.

Authors:  Carolyn S Kaufman; Jaime Perales-Puchalt
Journal:  Int Psychogeriatr       Date:  2019-10       Impact factor: 3.878
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.